arrow
S

Sandra Gofinet Pasoto

Universidade de São Paulo
H指数:31
被引数:3,202

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lower magnitude of humoral response to recombinant herpes zoster vaccine in immunocompromised Sjögren's disease patients: evidence from a randomized double-blinded placebo-controlled trial

免疫缺陷性舍格伦综合征患者对重组带状疱疹疫苗的体液反应程度较低:来自一项随机双盲安慰剂对照试验的证据

2026-05-230
PRE
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study

重组带状疱疹疫苗在巴西自身免疫性风湿病患者的应用:一项双盲、随机、安慰剂对照、IV期、非劣效性研究

2026-02-090
PRE
VII Brazilian Consensus guidelines for the detection and interpretation of anti-cell autoantibodies on HEp-2 cells

VII巴西共识指南:HEp-2细胞上抗细胞自身抗体的检测与解读

2025-11-250
OA
Associations of local bone involvement with disease activity, damage and functional disability in Sjogren's disease: A cross-sectional study

局部骨质受累与干燥综合征疾病活动度、损害及功能残疾的相关性:一项横断面研究

2025-04-010
PRE
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering
2024-07-143
PRE
OFF-LABEL USE OF BIOLOGICS AND SMALL MOLECULES IN SJÖGREN DISEASE: REAL-WORLD DATA FROM THE INTERNATIONAL SJÖGREN BIG DATA COHORT

生物制剂和小分子在舍格伦综合征中的超说明书用药:国际舍格伦大数据队列的真实世界数据

2024-06-010
PRE
Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study
2023-07-0110
OAAI
A randomized controlled trial of an intervention promoting physical activity and healthy eating recommendations in systemic lupus erythematosus: the protocol study Living Well with Lupus

一项促进身体活动和健康饮食建议的干预措施在系统性红斑狼疮中的随机对照试验: 狼疮患者生活良好的协议研究

2023-06-244
PRE
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis
2023-01-0110
OAAI
Characterisation of the coexistence between sarcoidosis and Sjogren's syndrome. Analysis of 43 patients
2022-12-202
OA
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
2022-10-036
OAAI
Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients
2022-07-263
OA
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus
2022-03-0425
OA
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases
2022-03-0117
OAAI